X @Bloomberg

Business Strategy - Novo Nordisk cut its cell therapy division focused on type 1 diabetes cure [1] - The company is slashing headcount to focus on lucrative areas of obesity and diabetes treatment [1] Industry Focus - The company is prioritizing obesity and diabetes treatment areas [1]